---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-062802"
form_type: "8-K"
ticker: "CERO"
cik: "0001870404"
company_name: "CERO THERAPEUTICS HOLDINGS, INC."
filed_at: "2026-05-29T20:05:17+00:00"
generated_at: "2026-05-29T20:08:48.664702+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CERo Therapeutics issues $750K convertible note at 10% interest, convertible at $0.05 floor

## Summary
- Issued $750K convertible promissory note ($937.5K face value) to SRX Health Solutions, maturing May 28, 2027.
- Note bears 10% interest; conversion price is lesser of $0.05 or 80% of average 5 lowest intraday prices in prior 20 days.
- Company must file resale registration statement for shares issuable upon conversion; beneficial ownership cap of 4.99% applies.
- Issuance exempt under Section 4(a)(2) and Rule 506(b); lender is accredited investor.

## SEC filing metadata
- accession: 0001213900-26-062802
- form_type: 8-K
- ticker: CERO
- cik: 0001870404
- company_name: CERO THERAPEUTICS HOLDINGS, INC.
- filed_at: 2026-05-29T20:05:17+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1870404/000121390026062802/0001213900-26-062802-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1870404/000121390026062802/ea0292715-8k_cero.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-062802
- JSON: https://secwatch.observer/filing/0001213900-26-062802.json
- Plain text: https://secwatch.observer/filing/0001213900-26-062802.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.